{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:25:31Z","timestamp":1789748731641,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.clinthera.2010.10.003","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T09:11:28Z","timestamp":1290417088000},"page":"1977-1986","source":"Crossref","is-referenced-by-count":4,"title":["Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: An open-label, randomized-sequence, two-period crossover study"],"prefix":"10.1016","volume":"32","author":[{"given":"Shaojun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fandian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.10.003_bib1","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1056\/NEJM199411173312008","article-title":"Fluoxetine","volume":"331","author":"Gram","year":"1994","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2010.10.003_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0013-7006(04)95453-X","article-title":"Fluoxetine: An update of its use in major depressive disorder in adults [in French]","volume":"30","author":"Gourion","year":"2004","journal-title":"Encephale."},{"key":"10.1016\/j.clinthera.2010.10.003_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ps.58.1.128","article-title":"Generic fluoxetine and choice of antidepressant medication","volume":"58","author":"Sernyak","year":"2007","journal-title":"Psychiatr Serv."},{"key":"10.1016\/j.clinthera.2010.10.003_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/138920006775541561","article-title":"Fluoxetine metabolism and pharmacological interactions: The role of cytochrome p450","volume":"7","author":"Mandrioli","year":"2006","journal-title":"Curr Drug Metab."},{"key":"10.1016\/j.clinthera.2010.10.003_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00003088-199426030-00004","article-title":"Clinical pharmacokinetics of fluoxetine","volume":"26","author":"Altamura","year":"1994","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.clinthera.2010.10.003_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jat\/31.7.409","article-title":"The distribution of fluoxetine in human fluids and tissues","volume":"31","author":"Johnson","year":"2007","journal-title":"J Anal Toxicol."},{"key":"10.1016\/j.clinthera.2010.10.003_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00007691-200210000-00006","article-title":"Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: Sources of variability and preliminary observations on relations with clinical response","volume":"24","author":"Jannuzzi","year":"2002","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.clinthera.2010.10.003_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.1993.43","article-title":"Inhibition by fluoxetine of cytochrome P450 2D6 activity","volume":"53","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.10.003_bib10","series-title":"International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice. ICH Topic E 6 (R1)","year":"2002"},{"key":"10.1016\/j.clinthera.2010.10.003_bib11","series-title":"Guidance for industry: Bioavailability and bioequivalence studies for orally administered drug products-general considerations","year":"2003"},{"key":"10.1016\/j.clinthera.2010.10.003_bib12","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/rcm.800","article-title":"Liquid chromatography\/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard","volume":"16","author":"Li","year":"2002","journal-title":"Rapid Commun Mass Spectrom."},{"key":"10.1016\/j.clinthera.2010.10.003_bib13","series-title":"Guidance for industry: Bioanalytical method validation","year":"2001"},{"key":"10.1016\/j.clinthera.2010.10.003_bib14","year":"2005","journal-title":"Guidance for Bioavailability and Bioequivalence Studies for Chemical Drug Products in Humans"},{"key":"10.1016\/j.clinthera.2010.10.003_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","article-title":"A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability","volume":"15","author":"Schuirmann","year":"1987","journal-title":"J Pharmacokinet Biopharm."},{"key":"10.1016\/j.clinthera.2010.10.003_bib16","series-title":"Guidance for industry: Statistical approaches to establishing bioequivalence","year":"2001"},{"key":"10.1016\/j.clinthera.2010.10.003_bib17","first-page":"562","article-title":"Functions of the DAS software for pharmacological calculation","volume":"7","author":"Chen","year":"2002","journal-title":"Chin J Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.10.003_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/00912709922011827","article-title":"Fluoxetine bioequivalence study: Quantification of fluoxetine and norfluoxetine by liquid chromatography coupled to mass spectrometry","volume":"39","author":"Moraes","year":"1999","journal-title":"J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.10.003_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00228-003-0707-y","article-title":"Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions","volume":"59","author":"LLerena","year":"2004","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.10.003_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1742-7843.2005.pto_194.x","article-title":"Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steadystate plasma concentrations of the enantiomers of fluoxetine and norfluoxetine","volume":"97","author":"Scordo","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"10.1016\/j.clinthera.2010.10.003_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.10.003_bib22","first-page":"31","article-title":"Genetic polymorphism of cytochrome P450 enzymes in Asian populations: Focus on CYP 2D6","volume":"23","author":"Kitada","year":"2003","journal-title":"Int J Clin Pharmacol Res."},{"key":"10.1016\/j.clinthera.2010.10.003_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinchem\/48.7.983","article-title":"Singlestep assays to analyze CYP2D6 gene polymorphisms in Asians: Allele frequencies and a novel *14B allele in mainland Chinese","volume":"48","author":"Ji","year":"2002","journal-title":"Clin Chem."},{"key":"10.1016\/j.clinthera.2010.10.003_bib24","first-page":"18","article-title":"Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population [published correction appears in Clin Chem. 2000; 46:1873]","volume":"46","author":"Garcia-Barcel\u00f3","year":"2000","journal-title":"Clin Chem."},{"key":"10.1016\/j.clinthera.2010.10.003_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF00316090","article-title":"Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations","volume":"39","author":"Alv\u00e1n","year":"1990","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.10.003_bib26","first-page":"491","article-title":"Bioequivalence study of fluoxetine hydrochloride in healthy volunteers","volume":"55","author":"Keller","year":"2005","journal-title":"Arzneimittelforschung"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T00:39:20Z","timestamp":1592095160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810003425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0149291810003425"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.10.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}